glp 1 antagonist exendin Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway Achieve your results faster with highly validated Exendin(9‐39)NH2: Recommendations for clinical use
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



























